NCT01591902 Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA® Status TERMINATED Phase PHASE4
NCT01517490 Retinal Adaptation to Intensified Insulin Therapy and Bariatric Surgery in Patients With Diabetes Status UNKNOWN Phase N/A
NCT01487629 Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular Edema Status UNKNOWN Phase PHASE2
NCT01476449 Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema Status COMPLETED Phase PHASE2
NCT01445899 PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) Status COMPLETED Phase PHASE2
NCT01440660 Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER) Status COMPLETED Phase N/A
NCT01382498 Effect of Doxium on High Sensitivity CRP and Endothelin-1 Serum Levels in Patients With Diabetic Retinopathy Status UNKNOWN Phase PHASE4
NCT01375166 Coupling of Neural Activity and Retinal Blood Flow in Diabetes Status TERMINATED Phase N/A
NCT01373476 Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy Status COMPLETED Phase PHASE2
NCT01364129 The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy Status COMPLETED Phase NA
NCT01323348 Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control Status COMPLETED Phase PHASE3
NCT01320345 The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01306981 Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot Study Status COMPLETED Phase PHASE4
NCT01304225 Panretinal Photocoagulation for Diabetic Retinopathy With PASCAL Laser Status UNKNOWN Phase PHASE3
NCT01298076 Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema Status COMPLETED Phase PHASE2